Vaccine composition
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Feb 26, 2004
app pub date -
Apr 4, 2003
filing date -
Oct 6, 2000
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention concerns a vaccine composition comprising at least an antigen, a cationic lipid and an immunostimulatory oligonucleotide. Said vaccine composition is particularly designed to induce an immune response of the Th1 type and a cytotoxic T response when administered by parenteral delivery, and to induce a Th2 type immune response when delivered through the mucous system. Said composition is of particular interest when the cationic lipid is DC chol.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully